Literature DB >> 16168848

Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy.

Emile N J Th van Lin1, Aswin L Hoffmann, Peter van Kollenburg, Jan Willem Leer, Andries G Visser.   

Abstract

PURPOSE: To investigate the dosimetric consequences and rectal wall (Rwall) sparing effect of three different endorectal balloons (ERBs) for three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) for prostate cancer. METHODS AND MATERIALS: In 20 patients, 4 planning computed tomography scans were made: 1 without ERB and 3 with ERB1, ERB2, or ERB3 inserted. Two different planning target volumes were defined: prostate only, and prostate plus seminal vesicles. The 3D-CRT and IMRT planning techniques were used, and the prescription dose was 78 Gy. In 284 treatment plans, the Rwall mean dose, the Rwall normal tissue complication probability, and the absolute Rwall volumes exposed to > or =50 Gy (V(50)) and > or =70 Gy (V(70)) were calculated. For spatial dose distribution analysis, inner rectal wall dose maps and dose surface histograms were generated.
RESULTS: Each ERB was tolerated well. In the case of 3D-CRT, each ERB showed a statistically significant reduction of all the measured parameters. ERB2 and ERB3 performed better than ERB1. In IMRT, a statistically significant reduction in the Rwall dose parameters could not be demonstrated for any of the ERBs. For 3D-CRT and IMRT, as a result of the rectal dilation, ranging from 8 to 20 cm in circumference, the ERBs resulted in a reduction of the relative inner Rwall surface exposed to intermediate and high doses.
CONCLUSIONS: In 3D-CRT, any ERB showed a significant rectal wall sparing effect. ERB2 and ERB3 were superior to ERB1. For both 3D-CRT and IMRT, a reduction of the relative inner Rwall surface exposed to intermediate and high doses was found, which may lead to reduced late rectal toxicity. Development of user- and patient-friendly ERBs is warranted to increase their acceptability.

Entities:  

Mesh:

Year:  2005        PMID: 16168848     DOI: 10.1016/j.ijrobp.2005.05.010

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer.

Authors:  Kenji Takayama; Takashi Mizowaki; Yoshiharu Negoro; Yoshiki Norihisa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-05       Impact factor: 3.402

Review 2.  Radiation proctopathy.

Authors:  Marc B Grodsky; Shafik M Sidani
Journal:  Clin Colon Rectal Surg       Date:  2015-06

3.  In vivo real-time rectal wall dosimetry for prostate radiotherapy.

Authors:  Nicholas Hardcastle; Dean L Cutajar; Peter E Metcalfe; Michael L F Lerch; Vladimir L Perevertaylo; Wolfgang A Tomé; Anatoly B Rosenfeld
Journal:  Phys Med Biol       Date:  2010-07-07       Impact factor: 3.609

4.  Verification of the dose attenuation of a newly developed vacuum cushion for intensity-modulated radiation therapy of prostate cancer.

Authors:  Toru Takakura; Yoshiyuki Ito; Akinori Higashikawa; Tomohiro Nishiyama; Takashi Sakamoto
Journal:  Radiol Phys Technol       Date:  2016-06-03

Review 5.  Effectiveness of rectal displacement devices in managing prostate motion: a systematic review.

Authors:  Mahdieh Afkhami Ardekani; Hamed Ghaffari; Mahmoud Navaser; Seyed Hamid Zoljalali Moghaddam; Soheila Refahi
Journal:  Strahlenther Onkol       Date:  2020-05-22       Impact factor: 3.621

Review 6.  Reducing rectal injury during external beam radiotherapy for prostate cancer.

Authors:  Riccardo Valdagni; Tiziana Rancati
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

Review 7.  Gastrointestinal radiation injury: prevention and treatment.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 8.  Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

Authors:  Stefano Arcangeli; Carlo Greco
Journal:  Nat Rev Urol       Date:  2016-06-14       Impact factor: 14.432

9.  Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.

Authors:  Lynsey J Hamlett; Andrew J McPartlin; Edward J Maile; Gareth Webster; Ric Swindell; Carl G Rowbottom; Ananya Choudhury; Adam H Aitkenhead
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

10.  Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.

Authors:  Curtiland Deville; Stefan Both; Viet Bui; Wei-Ting Hwang; Kay-See Tan; Mattia Schaer; Zelig Tochner; Neha Vapiwala
Journal:  Radiat Oncol       Date:  2012-05-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.